ArticleNature communications2025
Divergent roles of m
Abstract read
In one paragraph
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Bibliometric analysis of RNA-binding proteins in osteosarcoma: unraveling research trends and hotspots.Frontiers in immunology · 2025Pooled it
- ALKBH5 activates creatine-driven thermogenesis by stabilizing CKB mRNA in response to cold.Nature metabolism · 2026Article
- Mettl14-mediated mJournal of endocrinological investigation · 2026Article
- The Role of NMedComm · 2026Review
- N6-methyladenosine (m6A) methylation in adipose tissue: role, regulation, and therapeutic potential.Cellular and molecular life sciences : CMLS · 2026Review
- Dynamic m⁶A methylation during bovine preadipocyte differentiation and functional implication of the m⁶A writer METTL14.BMC genomics · 2026Article
- NBiomolecules · 2026Review
- The emerging role of mFrontiers in immunology · 2026Review
- Epigenetic modifier m⁶A methylation: insights into the pathogenesis and therapeutic potential of autoimmune diseases.Journal of translational medicine · 2025Review
- mAmerican journal of physiology. Gastrointestinal and liver physiology · 2025Article
- Current Insights into Obesity and mBiomedicines · 2025Review
- Targeting RNA adenosine editing and modification enzymes for RNA therapeutics.Molecular therapy : the journal of the American Society of Gene Therapy · 2025Review
- Epitranscriptomic Role of m6A in Obesity-Associated Disorders and Cancer Metabolic Reprogramming.Genes · 2025Review
- RNA Modification in Metabolism.MedComm · 2025Review
- M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges.Frontiers in oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Ling Xiao *Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Department of Medicine, BIDMC; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Dario F De Jesus *Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Department of Medicine, BIDMC; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8826-9095
Cheng-Wei Ju *Department of Chemistry, Howard Hughes Medical Institute, The University of Chicago, Chicago, USA.ORCID http://orcid.org/0000-0002-2250-8548
Jiang-Bo WeiDepartment of Chemistry, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0003-2691-6490
Jiang HuSection of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Department of Medicine, BIDMC; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Ava DiStefano-FortiSection of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Department of Medicine, BIDMC; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Valeria Salerno GonzalesSection of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Department of Medicine, BIDMC; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Tadataka TsujiSection on Integrative Physiology and Metabolism, Joslin Diabetes Center; Department of Medicine, BIDMC, Harvard Medical School; Harvard Stem Cell Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2837-8246
Siying WeiSection of Islet Cell and Regenerative Biology, and CRISPR Screen Core Laboratory, Joslin Diabetes Center; Department of Medicine, BIDMC; Harvard Medical School, Boston, MA, USA.
Matthias BlüherHelmholtz Institute for Metabolic, Obesity and Vascular Research, HI, Leipzig, Germany.ORCID http://orcid.org/0000-0003-0208-2065
Yu-Hua TsengSection on Integrative Physiology and Metabolism, Joslin Diabetes Center; Department of Medicine, BIDMC, Harvard Medical School; Harvard Stem Cell Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2053-9559
Chuan HeDepartment of Chemistry, Howard Hughes Medical Institute, The University of Chicago, Chicago, USA.ORCID http://orcid.org/0000-0003-4319-7424
Rohit N KulkarniSection of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Department of Medicine, BIDMC; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA. Rohit.Kulkarni@joslin.harvard.edu.ORCID http://orcid.org/0000-0001-5029-6119
Funding
SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5MTranscriptome-wide base-resolution sequencing of pseudouridine in human normal and AD brain tissues-CEGS Admin supplement 2020-2021RM1HG008935 · NHGRI · UNIVERSITY OF CHICAGO · PI HE, CHUAN · 2016 to 2025
$24.4MPilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6MRole of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0MEpitranscriptomics in human obesity and type 2 diabetesRC2DK139552 · NIDDK · JOSLIN DIABETES CENTER · PI Mengjie Chen, CHUAN HE · 2024 to 2026
$6.0MFibroblast Growth Factor and Energy MetabolismR01DK102898 · NIDDK · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2015 to 2024
$4.1MTranscriptional and epigenetic regulation of thermogenic adipocyte programR01DK132469 · NIDDK · JOSLIN DIABETES CENTER · PI Yu-Hua Tseng · 2022 to 2026
$3.0MDissecting the thermogenic adipose nicheR01DK133528 · NIDDK · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2022 to 2025
$2.8MRole of brown fat-derived specialized pro-resolving lipid mediators in inflammation and metabolismR01DK122808 · NIDDK · JOSLIN DIABETES CENTER · PI SPITE, MATTHEW R, TSENG, YU-HUA · 2020 to 2023
$2.2MInterrogation of dynamic RNA modifications in beta cells in type 1 diabetesUC4DK116278 · NIDDK · JOSLIN DIABETES CENTER · PI HE, CHUAN, KULKARNI, ROHIT N. · 2017 to 2017
$1.9MSmall Animal High Resolution Metabolic Analysis SystemS10OD028568 · OD · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2020 to 2020
$573kInterrogating the role of m6A mRNA methylation in the aging of the β-cell and diabetesR00DK135927 · NIDDK · UNIVERSITY OF CHICAGO · PI Dario F De Jesus · 2025 to 2026
$498kAmerican Heart Association-American Stroke Association 903968NHGRI NIH HHS RM1 HG008935NIDDK NIH HHS K99 DK135927NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R00 DK135927NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK102898NIDDK NIH HHS R01 DK122808NIDDK NIH HHS R01 DK132469NIDDK NIH HHS R01 DK133528NIDDK NIH HHS RC2 DK139552NIDDK NIH HHS UC4 DK116278NIEHS NIH HHS P30 ES027792NIH HHS S10 OD028568U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01 DK67536
Abstract
N
Indexed as
AdenosineAdipocytes, WhiteApoptosisInsulin ResistanceMethyltransferasesMice, KnockoutTranscriptomeAdipocytes, BrownAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsHumansMaleMiceMice, Inbred C57BLReceptors, Tumor Necrosis Factor, Type IAdenosineMethyltransferasesMETTL14 protein, humanMettl14 protein, mouseN-methyladenosineReceptors, Tumor Necrosis Factor, Type IRNA, MessengerTNF-Related Apoptosis-Inducing Ligand
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.